首页> 外国专利> MEDULLOBLASTOMA GENES AS TARGETS FOR DIAGNOSIS AND THERAPEUTICS

MEDULLOBLASTOMA GENES AS TARGETS FOR DIAGNOSIS AND THERAPEUTICS

机译:髓母细胞基因作为诊断和治疗的目标

摘要

Medulloblastoma (MB) is the most common malignant brain tumor of children. To identify the genetic alterations in this tumor type, we searched for copy number alterations using high density microarrays and sequenced all known protein-coding genes and miRNA genes using Sanger sequencing. We found that, on average, each tumor had 11 gene alterations, markedly fewer than in common adult cancers. In addition to alterations in the Hedgehog and Wnt pathways, our analysis led to the discovery of genes not previously known to be altered in MBs. Most notably, inactivating mutations of the histone H3K4 trimethylase genes MLL2 or MLL3 were identified in 16% of MB patients. These results demonstrate key differences between the genetic landscapes of adult and childhood cancers, highlight dysregulation of developmental pathways as an important mechanism underlying MBs, and identify a role for a specific type of histone methylation in human tumorigenesis.
机译:髓母细胞瘤(MB)是儿童最常见的恶性脑肿瘤。为了确定这种肿瘤类型的遗传变异,我们使用高密度微阵列搜索了拷贝数变异,并使用Sanger测序对所有已知的蛋白质编码基因和miRNA基因进行了测序。我们发现,平均而言,每个肿瘤都有11种基因改变,明显少于普通成人癌症。除了刺猬和Wnt途径的改变外,我们的分析还导致发现了以前未知的可在MBs中改变的基因。最值得注意的是,在16%的MB患者中发现了组蛋白H3K4三甲基酶基因MLL2或MLL3的失活突变。这些结果证明了成年和儿童期癌症的遗传格局之间的关键差异,突显了发育途径的失调,这是MB的重要机制,并确定了特定类型的组蛋白甲基化在人类肿瘤发生中的作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号